title: US Food and Drug Administration Regulation of Medical Devices and Radiation Oncology: Can Reform Improve Safety?
abstract: Although radiation therapy is highly safe and effective in treating cancer, recent reports of dangerous radiation-related errors have focused a national spotlight on the field of radiation oncology and, more specifically, on the rapidly evolving and complex nature of radiation devices and how they are regulated. The purpose of this review is to explore the issues involved in medical device regulation in radiation oncology. We start with a general review of federal medical device regulation, including explanations of the legal and regulatory framework, and then discuss issues specific to radiation oncology with real-world examples. We also provide our thoughts on potential solutions and reforms to the current system, including better reporting of radiation-related errors in a centralized database, well-defined criteria for establishing substantial equivalence of a new device, and standard postmarket surveillance of radiation devices. Modern radiation therapy is a powerful tool that can help cure many patients' cancers and alleviate others' suffering with limited adverse effects. We must ensure that this promise is never compromised by avoidable mistakes.
authors.affiliation: Harvard Radiation Oncology Program; Beth Israel Deaconess Medical Center-Harvard Medical School, Boston, MA; and University of Cincinnati College of Law, Cincinnati, OH.
authors.forename: Jona A
authors.initials: JA
authors.lastname: Hattangadi
authors.forename: James T
authors.initials: JT
authors.lastname: O'Reilly
authors.forename: Abram
authors.initials: A
authors.lastname: Recht